Early Phase 1 Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with cystic fibrosis
- You are between 18 and 45 years old
- You are male or female, of any race or ethnicity
- You are currently taking a highly effective CFTR modulator therapy (a type of medication used to treat cystic fibrosis)
Who may not be able to join:
- You have had an organ transplant
- You have had a significant drop in lung function or a lung flare-up in the last 3 months
- You are currently taking steroid medications by mouth or injection (such as prednisone or cortisone)
- You are currently pregnant
- You have a known liver condition that doctors believe could significantly affect the study's test results
- You have any other illness or condition that a study doctor believes could interfere with test results or make taking part unsafe for you (confirm with trial site)
- You have a cognitive impairment that affects your ability to understand or participate
- You do not speak English
- If you have cystic fibrosis-related diabetes, your daily insulin dose is more than 0.8 units per kilogram of your body weight per day
- You have ever had a serious diabetes-related emergency called diabetic ketoacidosis (a dangerous build-up of acids in the blood)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jason Winnick, PhD, University of Cincinnati
Phone: 513-558-4437
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Concentration of Insulin; Concentration of Glucagon; Concentration of Somatostatin; Concentration of Glucose
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.